Improvement of NASH with two-year treatment with oral polyenephosphatidylcholine
10.2185/jrm.2.67
- Author:
Hiroyuki Ohbayashi
;
Masao Fujimoto
;
Hirohiko Yamase
;
Masafumi Ito
- Publication Type:Journal Article
- MeSH:
therapeutic aspects;
month;
Diagnostic Neoplasm Staging;
agreement;
Oral
- From:Journal of Rural Medicine
2006;2(1):67-73
- CountryJapan
- Language:Japanese
-
Abstract:
A 46-year-old female patient with non-alcoholic steatohepatitis (NASH) was administered nateglinide, an insulin secretagogue, for 7 months, and then polyenephosphatidylcholine, an anti-oxidant medication, in accordance with the two-step hypothesis of NASH, with insulin resistance as the initial pathogenesis and oxidative stress as the second. HOMA-R, an index of insulin resistance, improved, and hepatic marker levels improved markedly by four weeks after initiation of polyenephosphatidylcholine. The beneficial effects of treatment continued over the 24 months of the study. A liver biopsy evaluated using Brunt's criteria showed improvement from stage 2 to stage 0 after 9 months. These findings suggest the therapeutic efficacy of step by step treatment of NASH in accordance with the two-stage hypothesis.
